Dilpacimab
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer[1].
Product Specifications
CAS Number
1791420-09-1
Product Name Alternative
ABT165; PR1283233
UNSPSC
12352203
Target
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dilpacimab.html
Purity
96.88
Solubility
10 mM in DMSO
Smiles
[Dilpacimab]
Molecular Weight
(199.12 kDa)
References & Citations
[1]Gordon MS, et, al. Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. Mol Cancer Ther. 2021 Oct;20 (10) :1988-1995.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IHUMSRSPO1RLY5UG 5 µg
Human, Mouse R-Spondin-1 Recombinant Protein Lyophilized 5UG
Sign In for Pricing
View Details 